Clinical trial
Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients (NOAC-GAP) - a Randomised Controlled Study
NCT03785080 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients (NOAC-GAP) - a Randomised Controlled Study
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 11, 2019
- Completion date
- December 30, 2025
- Enrollment
- 552 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
upper gastrointestinal bleeding